Dural Arteriovenous Fistulas Treatment Market to Enlist Popularity rate at ~ 7.68% of CAGR from 2017 to 2023

Market Research Future (MRFR)
This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the global Dural Arteriovenous Fistulas Treatment Market over the forecast period.

“Medtronic, Inc. Presents at 2017 Connected Health Conference, Oct-27-2017 12:40 PM. Oct 24 17” Medtronic, Inc. Presents at 2017 Connected Health Conference, Oct-27-2017 12:40 PM. Venue: Seaport World Trade Center, Boston, Massachusetts, United States. Speakers: Ernie Rapoza, Sr.

Market Research Future published new report, titled “Dural Arteriovenous Fistulas Treatment Market -Research Report: Global Forecast till 2023”.

This report provides in depth study of “Dural Arteriovenous Fistulas Treatment Market 2017 Global Industry Research Report focuses on industry chain structure, market Size, Share, opportunities, future roadmap, industry analysis, industry policy analysis, market Leading player profiles and strategies. This New Report presented by Market Research Future contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. Further MRFR asserts that the Market will demonstrate a colossal growth by 2023. The global Dural Arteriovenous Fistulas Treatment market is expected to grow at a CAGR of ~ 7.68 % during the forecast period (2017 – 2023).

Competition in the Global Dural Arteriovenous Fistulas Treatment Market and are profiled in MRFR Analysis. “Global Dural Arteriovenous Fistulas Treatment Market by Manufacturers, Countries, Type and Application, Forecast to 2023 Report “Provides In-Depth Analysis Of Parent Market Trends, Macro-Economic Indicators And Governing Factors Along With Market Attractiveness As Per Segments.

Some of Key Players in the market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited.

“Investors Reportedly Seeks To Acquire Sutures India – Aug 21 17” Investors, including two leading medical devices makers and two private equity (PE) investors, have submitted bids for a majority stake in Sutures India Private Limited (Healthium Medtech Pvt. Ltd), two people aware of the development said. TPG Capital, L.P., which holds a 73% stake in TPG Growth, is planning to sell a controlling stake in Sutures India.
 
“Teleflex Incorporated Signs New Agreement with HealthTrust for Respiratory Heaters & Accessories- Dec 12 17” Teleflex Incorporated has announced that its respiratory division has signed a new group purchasing agreement with HealthTrust. The Respiratory Heaters & Accessories agreement (HPG-6071) which became effective December 1, 2017, covers Teleflex’s full line of Active Humidification, Non Invasive Ventilation (NIV), and High Flow Nasal Cannula Therapy (HFNCT) products.

Market Highlights

Dural arteriovenous fistula is an abnormal connection between an artery and a vein. Any organ of the body can suffer from fistula. The brain is bounded by a tough fibrous cover called dura mater or dura. When a fistula forms between an artery and a vein within the dura, it is called brain dural fistula.

According to Migraine Research Foundation, migraine was the 3rd most prevalent illness in the world in 2014. The prevalence of migraine is very high in the US, which is nearly 1 in 4 people. Moreover, 18% of American women, 6% of men, and 10% of children experience migraines. Mostly migraine occurs at the age of 25-55.

Increasing prevalence of neurological disorder such as epilepsy and migraine leads to dural arteriovenous fistulae, and increasing investment in biotechnology and pharmaceutical industries in R&D drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology projected to fuel the market growth during the forecast period. However, high cost of the treatment may slow the market growth in the same period.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/4589 . 

Segmentations:

The global dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.

On the basis of type, the market is segmented into type I, type II, and type III.

On the basis of application, the market is segmented into surgery, stereotactic radiosurgery, embolization, and others.

On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others.

Regional Analysis:

The Americas dominates the global dural arteriovenous fistulae treatment market owing to the presence of huge patient population with brain injury and neurological disorder such as depression, epilepsy, and migraine, high healthcare spending, and increasing government support for research & development.

Europe holds the second largest share of the global dural arteriovenous fistulae treatment market. The increasing focus of various government agencies on treating epilepsy, depression, and heart attacks expected to have a positive impact on the growth of the market over the assessment period. Additionally, growing public awareness may boost the adoption of these devices in the European market.

Asia Pacific is the fastest growing dural arteriovenous fistulae treatment market across the globe. In this region, Japan holds the major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.  Furthermore, increasing patient population in India estimated to generate various new opportunities for the growth of the market in the given period.

The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East and African market. Whereas, the African region is expected to witness a moderate growth over the forecast period.

Major Table of Contents:

Chapter 1. Report Prologue
Chapter 2. 
Market Introduction    
Chapter 3. Research Methodology
Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Dural Arteriovenous Fistulae Treatment Market, By Type

Chapter 7. Global Dural Arteriovenous Fistulae Treatment Market, By Treatment

Chapter 8. Global Dural Arteriovenous Fistulae Treatment Market, By End User

Chapter 9. Global Dural Arteriovenous Fistulae Treatment Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix

…CONTINUED

GET DISCOUNT @ https://www.marketresearchfuture.com/check-discount/4589 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/dural-arteriovenous-fistulas-treatment-market-4589